Company Announcements

EBA Stress Test 2018

Source: RNS
RNS Number : 2587G
Bank of Ireland Group PLC
02 November 2018
 

Bank of Ireland Group plc (the ''Group'')

 

2018 EU-Wide Stress Test Results

 

2 November 2018

 

The Group was subject to the 2018 EU-wide stress test conducted by the European Banking Authority (EBA), in cooperation with the Central Bank of Ireland (CBI), the European Central Bank (ECB), and the European Systemic Risk Board (ESRB).

 

The stress test scenario was set by the ECB/ESRB and covers a three-year time horizon (2018-2020). In the stress test two scenarios were run; a baseline scenario and an adverse scenario which assumes a severe economic downturn. In the baseline scenario the Group maintains a CET1 ratio of 16.2% (regulatory) and 15.1% (fully loaded) in 2020. In the adverse scenario this ratio decreases to 11.1% (regulatory) and 8.9% (fully loaded) in 2020.

 

The Group's capital position is strong and the Group continues to organically generate capital. At the end of September 2018, the Group's fully loaded CET1 ratio was 13.5% and the Group's regulatory CET1 ratio was 15.1%. 

 

Detailed results of the stress test are published on the EBA's website. The relevant disclosure templates in relation to Bank of Ireland are also available on the Group's website at https://investorrelations.bankofireland.com/results-centre/other/

 

Ends

 

For further information please contact:

 

Bank of Ireland

 

Andrew Keating               Group Chief Financial Officer                                     +353 (0)766 23 5141

Darach O'Leary                 Head of Group Investor Relations                            +353 (0)766 24 4711

Damien Garvey                 Head of Communications                                          +353 (0)766 24 6716

 

 

 

 

Forward Looking Statement

 

This document contains forward-looking statements with respect to certain of the Bank of Ireland Group plc (the 'Company' or 'BOIG plc') and its subsidiaries' (collectively the 'Group' or 'BOIG plc Group') plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal,' 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward-looking.

 

Examples of forward-looking statements include among others, statements regarding the Group's near term and longer term future capital requirements and ratios, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations. Such forward-looking statements are inherently subject to risks and uncertainties, and hence actual results may differ materially from those expressed or implied by such forward-looking statements.

 

Nothing in this document should be considered to be a forecast of future profitability, dividends or financial position and none of the information in this document is or is intended to be a profit forecast, profit estimate or dividend forecast. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAXFAELKPFFF